You are viewing: North America Carrier Screening Market analysis
Part of: Carrier Screening Market (Global)

The North America Carrier Screening Market was valued at $1232.7 Million in 2023 and projected to reach to $3262.7 Million by 2028, representing a compound annual growth rate of 21.5%. North America's carrier screening market is poised for exceptional growth through 2028, driven by increasing awareness of genetic disorders, expanding insurance coverage for carrier testing, and technological advancements in genomic sequencing.

North America Carrier Screening Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Carrier Screening Market Trends and Insights

  • By 2028, North America is projected to reach $3,262.7 million, reflecting a robust compound annual growth rate of 21.5% that significantly outpaces global expansion trends.
  • This accelerated growth in North America is driven by heightened awareness of genetic disorders, expanded insurance coverage, and increasing adoption of non-invasive prenatal testing across the region. North America's carrier screening market benefits from advanced healthcare infrastructure, strong regulatory frameworks, and substantial investment in precision medicine initiatives.
  • The region's market expansion is supported by growing consumer demand for preventive genetic testing and the integration of carrier screening into routine prenatal care protocols.
  • North America continues to lead in technological advancement and clinical implementation, positioning the region as a key growth engine for the global carrier screening industry through 2028..

Key Market Statistics

  • CAGR (2023-2028) 21.5% CAGR
  • Market Size, 2023 ~USD 1232.7 Million
  • Forecast, 2028 ~USD 3262.7 Million
  • Geography North America

North America Carrier Screening Market Overview

Market Leadership Position :

North America commands the carrier screening market with a 2023 valuation of $1,232.7 million, establishing itself as the global epicenter for genetic testing innovation and adoption.

Exceptional Growth Trajectory :

North America's 21.5% CAGR significantly outpaces the global growth rate of 19.7%, demonstrating accelerated market expansion driven by advanced healthcare infrastructure and increasing genetic awareness.

Projected Market Expansion :

The region is forecasted to reach $3,262.7 million by 2028, representing a 165% increase from 2023 and solidifying North America's dominance in carrier screening technologies.

US Market Dominance :

The United States represents the largest market segment at $2,978.3 million, with Canada contributing $284.4 million, reflecting robust healthcare spending and genetic testing accessibility across the region.

North America Carrier Screening Market Dynamics

  • The region's sophisticated healthcare infrastructure, coupled with rising demand for personalized medicine and preventive genetic screening, creates a favorable environment for market expansion. Key growth catalysts include growing adoption among reproductive health providers, integration of carrier screening into routine prenatal care, and increasing consumer demand for comprehensive genetic risk assessment.
  • The competitive landscape continues to intensify with major diagnostic companies investing heavily in North American market penetration, while regulatory frameworks increasingly support genetic testing accessibility and reimbursement..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • North America's carrier screening market is valued at $1,232.7 million in 2023 and is expected to grow to $3,262.7 million by 2028, representing a 21.5% CAGR.
      • North America's growth rate of 21.5% significantly exceeds the global CAGR of 19.7%, establishing the region as a high-growth market for carrier screening services.
      • North America's market expansion is driven by advanced healthcare infrastructure, expanded insurance coverage, and increased adoption of non-invasive prenatal testing.
      • North America leads in technological innovation and clinical implementation, positioning the region as a key driver of global carrier screening market development.

      Carrier Screening Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment PULMONARY CONDITIONS (Medical Condition)
      Forecast Period 2023-2028
      Growth Rate CAGR of 19.7% from 2023 to 2028
      Largest Segment SERVICES (Product & Service)
      Market Size Base Year (Billions) ~USD 2.2 (2023)
      Revenue Forecast (Billions) ~USD 5.4 (2028)
      Segments Covered Product & Service, Type, Medical Condition, Technology, End User, Product & 2021-2028

      North America Carrier Screening Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product & Service

      • Products
      • Services

      By Type

      • Customized Panel Testing
      • Expanded Carrier Screening
      • Predesigned Panel Testing
      • Targeted Disease Carrier Screening

      By Medical Condition

      • Hematological Conditions
      • Neurological Conditions
      • Other Medical Conditions
      • Pulmonary Conditions

      By Technology

      • Dna Microarrays
      • Dna Sequencing
      • Other Technologies
      • Pcr

      By End User

      • Clinical Laboratories
      • Fertility Clinics
      • Hospitals And Medical Centers
      • Other End Users

      By Product & 2021-2028

      • Products
      • Services

      Target Audience

      • Diagnostic Laboratory Operators : Need regional market data to assess expansion opportunities, optimize service offerings, and understand competitive positioning within North America's high-growth carrier screening segment.
      • Healthcare Providers & Clinics : Require market insights to justify investments in genetic testing infrastructure, understand patient demand trends, and align service expansion with regional growth projections.
      • Medical Device & Biotech Companies : Seek detailed North American market analysis to guide product development, commercialization strategies, and go-to-market planning for carrier screening solutions.
      • Investment & Private Equity Firms : Need comprehensive market sizing and growth forecasts to evaluate investment opportunities in North American genetic testing companies and carrier screening platforms.
      • Insurance & Reimbursement Specialists : Require regional market data to understand coverage trends, reimbursement patterns, and growth drivers affecting carrier screening accessibility and adoption across North America.

      North America vs. other regions

      HowNorth America compares to the other 3 regional blocs covered in this market.

      Europe
      ~USD 1572.7 Million · 19.1% wtd CAGR ·
      Asia Pacific
      ~USD 357.4 Million · 13.7% wtd CAGR ·

      Countries within North America - compare and drill down

      Country2025 size (native)
      USUSD 2978.3 Million
      CanadaUSD 284.4 Million

      Country market size visualization

      US
      USD 2978.3 Million
      Canada
      USD 284.4 Million

      Reasons to Buy this Report

      • Regional Market Quantification : Access precise market sizing data for North America's carrier screening sector, including country-level breakdowns for the US ($2,978.3M) and Canada ($284.4M) to inform strategic planning.
      • Growth Opportunity Assessment : Leverage detailed CAGR analysis showing North America's 21.5% growth rate outpacing global trends, enabling identification of high-potential investment and expansion opportunities through 2028.
      • Competitive Intelligence : Understand North America's market dynamics, technological innovations, and regulatory landscape to benchmark competitive positioning and identify market entry or expansion strategies.
      • Forecast-Driven Decision Making : Utilize comprehensive 5-year projections reaching $3,262.7M by 2028 to develop accurate business forecasts, resource allocation plans, and revenue growth strategies specific to North America.
      • Stakeholder Alignment : Present data-backed market insights to investors, boards, and partners demonstrating North America's critical role in global carrier screening expansion and long-term profitability potential.

      Frequently asked questions

      What is the current size of the North America carrier screening market?

      The North America carrier screening market was valued at $1,232.7 million in 2023 and is projected to reach $3,262.7 million by 2028.

      What is the expected growth rate for North America's carrier screening market?

      North America's carrier screening market is expected to grow at a compound annual growth rate (CAGR) of 21.5% from 2023 to 2028.

      How does North America's carrier screening market growth compare to global trends?

      North America's CAGR of 21.5% exceeds the global CAGR of 19.7%, indicating that North America is growing faster than the overall global market.

      What factors are driving growth in North America's carrier screening market?

      Key drivers include advanced healthcare infrastructure, expanded insurance coverage, increased consumer awareness of genetic disorders, and growing adoption of non-invasive prenatal testing in North America.

      Why is North America a significant market for carrier screening?

      North America leads in technological innovation, has strong regulatory frameworks, substantial precision medicine investment, and integrated carrier screening into routine prenatal care protocols.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the Carrier Screening Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

      Secondary Research

      In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

      Primary Research

      Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons, Gynecologist, genetic consultant) and supply sides (Carrier Screening product/service providers and distributors).

      The following is a breakdown of the primary respondents:

      Breakdown of Primary Participants:

      Carrier Screening Market  Size, and Share

      Note 1: Others include sales managers, marketing managers, and product managers.

      Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the Carrier Screening Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry and markets have been identified through extensive secondary research
      • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Carrier Screening Market  Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Carrier Screening Market  Size, and Share

      Data Triangulation

      After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Carrier Screening Market industry.

      Market Definition

      Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive disease. Similarly, when it is done before or during pregnancy, it allows to find out the chances of having a child with a genetic disorder. Carrier screening involves testing a sample of blood, saliva, or tissue from the inside of the cheek.

      Market Stakeholders

      • Carrier screening product manufacturers, vendors, and distributors
      • Carrier screening service companies
      • Hospitals and private physician clinics
      • Reference laboratories
      • Donor banks
      • Health insurance payers
      • Research & consulting firms
      • Diagnostic Centers, and Medical Colleges
      • Research Institutes
      • Clinical Laboratories
      • Distributors of Carrier Screening Products and services

      Report Objectives

      • To define, describe, and forecast the global Carrier Screening Market based on Product & Service, Type, Medical Condition, Technology, End User, and Region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)  
      • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
      • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
      • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the Carrier Screening Market.

      Available Customizations:

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

      • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
      • Geographic Analysis:  Further breakdown of the European Carrier Screening Market into specific countries.  

      Get the Full Carrier Screening Market Report

      Full forecast, segment splits, and company analysis for all Carrier Screening Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status